319 related articles for article (PubMed ID: 17898703)
1. Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief.
Campa D; Gioia A; Tomei A; Poli P; Barale R
Clin Pharmacol Ther; 2008 Apr; 83(4):559-66. PubMed ID: 17898703
[TBL] [Abstract][Full Text] [Related]
2. Pilot study examining the frequency of several gene polymorphisms involved in morphine pharmacodynamics and pharmacokinetics in a morbidly obese population.
Lloret Linares C; Hajj A; Poitou C; Simoneau G; Clement K; Laplanche JL; Lépine JP; Bergmann JF; Mouly S; Peoc'h K
Obes Surg; 2011 Aug; 21(8):1257-64. PubMed ID: 20411349
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics and Morphine.
Ofoegbu A; B Ettienne E
J Clin Pharmacol; 2021 Sep; 61(9):1149-1155. PubMed ID: 33847389
[TBL] [Abstract][Full Text] [Related]
4. Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study.
Aubrun F; Zahr N; Langeron O; Boccheciampe N; Cozic N; Belin L; Hulot JS; Khiami F; Riou B
Eur J Anaesthesiol; 2018 Jul; 35(7):496-504. PubMed ID: 29474345
[TBL] [Abstract][Full Text] [Related]
5. Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?
Lötsch J; Zimmermann M; Darimont J; Marx C; Dudziak R; Skarke C; Geisslinger G
Anesthesiology; 2002 Oct; 97(4):814-9. PubMed ID: 12357145
[TBL] [Abstract][Full Text] [Related]
6. Combined analysis of circulating β-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects.
Rhodin A; Grönbladh A; Ginya H; Nilsson KW; Rosenblad A; Zhou Q; Enlund M; Hallberg M; Gordh T; Nyberg F
Mol Brain; 2013 Feb; 6():8. PubMed ID: 23402298
[TBL] [Abstract][Full Text] [Related]
7. Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer.
Fujita K; Ando Y; Yamamoto W; Miya T; Endo H; Sunakawa Y; Araki K; Kodama K; Nagashima F; Ichikawa W; Narabayashi M; Akiyama Y; Kawara K; Shiomi M; Ogata H; Iwasa H; Okazaki Y; Hirose T; Sasaki Y
Cancer Chemother Pharmacol; 2010 Jan; 65(2):251-8. PubMed ID: 19466410
[TBL] [Abstract][Full Text] [Related]
8. Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain.
Gong XD; Wang JY; Liu F; Yuan HH; Zhang WY; Guo YH; Jiang B
Asian Pac J Cancer Prev; 2013; 14(5):2937-43. PubMed ID: 23803057
[TBL] [Abstract][Full Text] [Related]
9. Genotypic screening of the main opiate-related polymorphisms in a cohort of 139 sickle cell disease patients.
Joly P; Gagnieu MC; Bardel C; Francina A; Pondarre C; Martin C
Am J Hematol; 2012 May; 87(5):534-6. PubMed ID: 22430884
[TBL] [Abstract][Full Text] [Related]
10. ABCB1 genetic polymorphisms affect opioid requirement by altering function of the intestinal P-glycoprotein.
Qin W; Zhang L; Wang X; Liu B; Xu L; Liu L; Fan B
Biomed Pharmacother; 2024 Jul; 176():116897. PubMed ID: 38850645
[TBL] [Abstract][Full Text] [Related]
11. Effects of
Zhao Z; Lv B; Zhao X; Zhang Y
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30455395
[TBL] [Abstract][Full Text] [Related]
12. Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Korean gynecologic patients.
Kim KM; Kim HS; Lim SH; Cheong SH; Choi EJ; Kang H; Choi HR; Jeon JW; Yon JH; Oh M; Shin JG
Int J Clin Pharmacol Ther; 2013 May; 51(5):383-92. PubMed ID: 23557865
[TBL] [Abstract][Full Text] [Related]
13. Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on postoperative morphine consumption.
Bastami S; Gupta A; Zackrisson AL; Ahlner J; Osman A; Uppugunduri S
Basic Clin Pharmacol Toxicol; 2014 Nov; 115(5):423-31. PubMed ID: 24703092
[TBL] [Abstract][Full Text] [Related]
14. Association of single nucleotide polymorphisms of ABCB1, OPRM1 and COMT with pain perception in cancer patients.
Wang XS; Song HB; Chen S; Zhang W; Liu JQ; Huang C; Wang HR; Chen Y; Chu Q
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):752-758. PubMed ID: 26489634
[TBL] [Abstract][Full Text] [Related]
15. Environmental and genetic factors associated with morphine response in the postoperative period.
Coulbault L; Beaussier M; Verstuyft C; Weickmans H; Dubert L; Trégouet D; Descot C; Parc Y; Lienhart A; Jaillon P; Becquemont L
Clin Pharmacol Ther; 2006 Apr; 79(4):316-24. PubMed ID: 16580900
[TBL] [Abstract][Full Text] [Related]
16. Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study.
Beer B; Erb R; Pavlic M; Ulmer H; Giacomuzzi S; Riemer Y; Oberacher H
PLoS One; 2013; 8(9):e75359. PubMed ID: 24086514
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers.
Lötsch J; von Hentig N; Freynhagen R; Griessinger N; Zimmermann M; Doehring A; Rohrbacher M; Sittl R; Geisslinger G
Pharmacogenet Genomics; 2009 Jun; 19(6):429-36. PubMed ID: 19514130
[TBL] [Abstract][Full Text] [Related]
18. Morphine metabolism, transport and brain disposition.
De Gregori S; De Gregori M; Ranzani GN; Allegri M; Minella C; Regazzi M
Metab Brain Dis; 2012 Mar; 27(1):1-5. PubMed ID: 22193538
[TBL] [Abstract][Full Text] [Related]
19. A functional polymorphism in the ATP-Binding Cassette B1 transporter predicts pharmacologic response to combination of nortriptyline and morphine in neuropathic pain patients.
Benavides R; Vsevolozhskaya O; Cattaneo S; Zaykin D; Brenton A; Parisien M; Verma V; Khoury S; Gilron I; Diatchenko L
Pain; 2020 Mar; 161(3):619-629. PubMed ID: 31738228
[TBL] [Abstract][Full Text] [Related]
20. Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study.
Margarit C; Roca R; Inda MD; Muriel J; Ballester P; Moreu R; Conte AL; Nuñez A; Morales D; Peiró AM
Pain Pract; 2019 Nov; 19(8):836-847. PubMed ID: 31269327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
